SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001100412-18-000030
Filing Date
2018-09-20
Accepted
2018-09-20 15:31:50
Documents
8
Period of Report
2018-09-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a92020188k.htm 8-K 36166
2 EXHIBIT 99.1 a9202018euapproval.htm EX-99.1 19689
3 a9202018euapproval001.jpg GRAPHIC 228550
4 a9202018euapproval002.jpg GRAPHIC 265224
5 a9202018euapproval003.jpg GRAPHIC 258887
6 a9202018euapproval004.jpg GRAPHIC 314361
7 a9202018euapproval005.jpg GRAPHIC 55878
8 a92020188kpressreleas_image1.jpg GRAPHIC 146580
  Complete submission text file 0001100412-18-000030.txt   1805731
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16633 | Film No.: 181079382
SIC: 2834 Pharmaceutical Preparations